<DOC>
	<DOCNO>NCT01611610</DOCNO>
	<brief_summary>The aim project establish network clinical team include major neuromuscular center Europe . We plan work together find best common outcome measure follow multicenter therapeutic trial .</brief_summary>
	<brief_title>Clinical Assessment Spinal Muscular Atrophy Type II III ( SMA Europe )</brief_title>
	<detailed_description>16 patient ( 6 ambulant 10 non ambulant ) , affect type II type III SMA enrol assessed baseline 6 12 month later . Non ambulant patient assess use modify version Hammersmith Motor Functional Scale ambulant patient assess use extend module Hammersmith Motor Functional Scale time item , 6 minute walk step activity monitor . All patient also assess use Motor Function Measure ( MFM ) , cover whole range activity ambulant non ambulant patient . All measure undergo process validation include inter observer reliability . This information valuable future trial make group involve ready participate future collaborative study save lot time preliminary aspect ( validation , reliability , train ) fulfil present study . The study also provide natural history data 12 month period patient SMA II III .</detailed_description>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Muscular Atrophy , Spinal</mesh_term>
	<mesh_term>Muscular Atrophy</mesh_term>
	<mesh_term>Spinal Muscular Atrophies Childhood</mesh_term>
	<criteria>Inclusion Criteria ambulant patient : age 30 month 24 year document SMA diagnosis genetic test ; Each also determination SMN2 copy number able walk 10 meter without support subject sign informed consent subject affiliate social security system Inclusion Criteria non ambulant patient : document diagnosis SMA genetic test able walk 10 meter without support subject affiliate social security system subject sign informed consent Patient currently involve clinical trial severe intellectual impairment limit comprehension demand task acute neurologic , inflammatory , infectious , endocrine , orthopedic disease month precede inclusion chronic neurologic ( besides SMA ) , inflammatory , infectious , endocrine , orthopedic disease natural consequence SMA spinal surgery schedule 6 month within 12 month enrollment pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>30 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>outcome measure</keyword>
	<keyword>spinal muscular atrophy</keyword>
</DOC>